Rate My Professor Peter Wipf

His research focuses on the total synthesis of natural products, strain-release and heterocyclic chemistry, and medicinal chemistry, with applications in chemical biology including projects on protein conformational diseases, radiation countermeasures, and chemical diversity. Key publications include "Nanoparticles in cellular drug delivery" (Bioorganic & Medicinal Chemistry, 2009), "Targeting mitochondria" (Accounts of Chemical Research, 2008), "Synthetic studies of biologically active marine cyclopeptides" (Chemical Reviews, 1995), and "Fluorous synthesis: A fluorous-phase strategy for improving separation efficiency in organic synthesis" (Science, 1997). With more than 45,000 citations, Wipf's contributions have advanced synthetic methodologies and drug discovery. He has received major awards such as the ACS Award for Creative Work in Synthetic Organic Chemistry (2023), Fellow of the National Academy of Inventors (2024), Humboldt Research Award (2014), Ernest Guenther Award (2009), and the 2026 E. C. Taylor Senior Award. Wipf has held editorial roles including Associate Editor of ACS Medicinal Chemistry Letters (2009-2022) and served on boards for Organic Syntheses and Organic Reactions, as well as chairing the NIH Medicinal Chemistry Study Section (2001-2003).